Weightloss
We provide weight loss with the use of semaglutide and tirzepatide.
Semaglutide
Contains one mechanism of action: A GLP-1 agonist
Decreases appetite, increases production of insulin, and increases satiety
Used for patients seeking weight loss, patients suffering from Polycystic Ovarian Syndrome (PCOS), and those with insulin resistance.
Dosed once weekly subcutaneously “under the skin”
Treatment with semaglutide requires recent lab work, which can be done in-office.
Tirzepatide
Contains two mechanisms of action: A GLP-1 agonist and a GIP
Decreases appetite, increases production of insulin, and increases satiety
Used for patients seeking weight loss, patients suffering from Polycystic Ovarian Syndrome (PCOS), and those with insulin resistance.
Dosed once weekly subcutaneously “under the skin”
Treatment with tirzepatide requires recent lab work, which can be done in-office.
